Product image of Micoxolamina (Ciclopirox Olamine) supplied by GNH India

Micoxolamina

Active Ingredient:
Ciclopirox Olamine
Origin:
EU

Micoxolamina (Ciclopirox Olamine)

Ciclopirox Olamine, the active ingredient in Micoxolamina, is an antifungal presented as a vaginal formulation for local use. It treats vulvovaginal candidiasis and other vaginal fungal infections in adult women. The medication is applied intravaginally and works directly at the site of infection, providing targeted therapy with minimal systemic absorption.

GNH India supplies Micoxolamina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Manufacturer / TM Owner

Mastelli S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Micoxolamina, a vaginal antifungal, is used to treat fungal infections of the vaginal mucosa.

  • Vulvovaginal candidiasis: reduces fungal load and alleviates symptoms such as itching, burning, and discharge.
  • Other vaginal fungal infections: eradicates non‑candidal yeasts and molds, restoring normal vaginal flora.
  • Recurrent vaginal fungal infection prophylaxis: may be used as a maintenance regimen to prevent recurrence in susceptible individuals.

How It Works

  • Ciclopirox Olamine exerts its antifungal activity by chelating polyvalent metal ions such as Fe³⁺ and Al³⁺, which are essential cofactors for fungal enzymes. This chelation disrupts the integrity of the fungal cell membrane and interferes with intracellular enzymatic processes, leading to inhibition of cellular respiration and synthesis of essential proteins, ultimately halting fungal growth and promoting cell death.

Side Effects

Micoxolamina may cause local and systemic adverse reactions, most of which are mild, reversible, and limited to the application site.

Common Side Effects

  • Vaginal irritation: mild burning or stinging at the application site.
  • Itching: localized pruritus in the vaginal area.
  • Discharge: increased vaginal discharge or spotting.
  • Odor change: temporary alteration in vaginal odor.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or hives indicating hypersensitivity.
  • Contact dermatitis: intense inflammation of the vaginal mucosa.
  • Stevens‑Johnson syndrome: rare but life‑threatening skin reaction.

Precautions & Warnings

Before using Micoxolamina, consider the following precautions to ensure safe and effective therapy.

  • Pregnancy: consult a healthcare professional before use, as safety data are limited.
  • Breastfeeding: discuss potential risks with a physician; use only if benefits outweigh risks.
  • Allergy: avoid if known hypersensitivity to ciclopirox olamine or any excipients.
  • Concomitant vaginal products: do not use simultaneously with other intravaginal medications or douches.
  • Severe mucosal irritation: discontinue if intense irritation or ulceration develops.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct light.

Avoid Interactions

Micoxolamina can interact with other agents; awareness of major and moderate interactions helps prevent adverse effects.

Major Interactions (Avoid)

  • Concurrent use of spermicidal agents: may increase local irritation.
  • Combination with other topical antifungals (e.g., azoles): risk of additive irritation.
  • Use with systemic antifungal therapy (e.g., fluconazole): may alter local drug absorption.

Moderate Interactions (Monitor Closely)

  • Vaginal douches or cleansers: can reduce drug efficacy.
  • Hormonal contraceptives: no direct interaction, but monitor for any changes in vaginal environment.
  • Lubricants containing irritants: may exacerbate local side effects.

Frequently Asked Questions

Micoxolamina is a vaginal antifungal formulation containing ciclopirox olamine. It is indicated for the treatment of vulvovaginal candidiasis and other fungal infections of the vagina, helping to relieve symptoms such as itching, burning, and abnormal discharge.

Ciclopirox olamine works by chelating essential metal ions needed for fungal enzyme activity. This disrupts the fungal cell membrane and interferes with intracellular processes, ultimately inhibiting fungal growth and leading to cell death at the site of infection.

The dosing regimen for Micoxolamina is determined by the prescribing healthcare professional. Typically, the product is applied intravaginally for a specific number of days as directed on the prescription label.

Safety data for Micoxolamina in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk, and the decision should be made in consultation with a qualified healthcare provider.

To order Micoxolamina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Micoxolamina (ciclopirox olamine) differs from azole antifungals such as clotrimazole or miconazole by its metal‑chelation mechanism, which may be effective against strains resistant to azoles. Both classes are topical, but ciclopirox offers an alternative when azole therapy fails or is not tolerated.

Store Micoxolamina at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

Micoxolamina is administered intravaginally. The prescribed amount is inserted into the vagina using the supplied applicator or as directed by the prescriber, typically once daily for the duration specified in the treatment plan.

Serious risks, although rare, include severe allergic reactions such as rash, swelling, hives, or anaphylaxis, and severe skin conditions like Stevens‑Johnson syndrome. Patients should discontinue use and seek immediate medical attention if any of these symptoms occur.

Micoxolamina should not be used by individuals with a known hypersensitivity to ciclopirox olamine or any of the product’s excipients. It should also be avoided in patients with severe mucosal irritation or ulceration until the condition is evaluated by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.